Skip to Main Content

Paper Details

Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study).
Discov Oncol
3
2023
GBM, Glioblastoma, glioblastoma, glioma, glioma cells, metformin, patients, temozolomide
Author NameAffiliation
Heon YooDepartment of Neuro-Oncology Clinic, Center for Specific Organs Cancer, National Cancer Center Hospital, National Cancer Center
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University School of Medicine
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University School of Medicine
  • 1 - 3

Datasets

Release 1.2